| Product Code: ETC7039250 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Angioedema Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Angioedema Market - Industry Life Cycle |
3.4 Egypt Angioedema Market - Porter's Five Forces |
3.5 Egypt Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Egypt Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Egypt Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Egypt Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Egypt Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Egypt Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Egypt Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema and its treatment options |
4.2.2 Growing healthcare infrastructure in Egypt |
4.2.3 Rising prevalence of angioedema cases in the region |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment centers for angioedema |
4.3.2 High costs associated with angioedema medications and therapies |
5 Egypt Angioedema Market Trends |
6 Egypt Angioedema Market, By Types |
6.1 Egypt Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Egypt Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Egypt Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Egypt Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Egypt Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Egypt Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Egypt Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Egypt Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Egypt Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Egypt Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Egypt Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Egypt Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Egypt Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Egypt Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Egypt Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Egypt Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Egypt Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Egypt Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Egypt Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Egypt Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Egypt Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Egypt Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Egypt Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Egypt Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Egypt Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Egypt Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Egypt Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Egypt Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Egypt Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Egypt Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Egypt Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Egypt Angioedema Market Import-Export Trade Statistics |
7.1 Egypt Angioedema Market Export to Major Countries |
7.2 Egypt Angioedema Market Imports from Major Countries |
8 Egypt Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in angioedema management |
8.2 Adoption rate of new angioedema treatment guidelines by healthcare providers |
8.3 Patient adherence rates to prescribed angioedema treatment regimens |
9 Egypt Angioedema Market - Opportunity Assessment |
9.1 Egypt Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Egypt Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Egypt Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Egypt Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Egypt Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Egypt Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Egypt Angioedema Market - Competitive Landscape |
10.1 Egypt Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Egypt Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here